After hours of deliberation over safety concerns, a Food and Drug Administration advisory panel on Wednesday recommended approval of a second vaccine for the respiratory syncytial virus in older adults, advancing the first shots against an illness that can be deadly for the very young and the very old.
#people #years #public-health #recommendations #disease-control #south-africa #astrazeneca #pfizer-vaccine #side-effects #hospitalizations
[
add
]
[
|
|
...
]